Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Matteo, Casenghi"'
Autor:
Pasquale Paolisso, Marta Belmonte, Emanuele Gallinoro, Roberto Scarsini, Luca Bergamaschi, Leonardo Portolan, Matteo Armillotta, Giuseppe Esposito, Elisabetta Moscarella, Giovanni Benfari, Claudio Montalto, Monika Shumkova, Elayne Kelen de Oliveira, Francesco Angeli, Mateusz Orzalkiewicz, Margherita Fabroni, Nurcan Baydaroglu, Andrea Raffaele Munafò, Daniele Oreste D’Atri, Matteo Casenghi, Lucia Scisciola, Michelangela Barbieri, Raffaele Marfella, Felice Gragnano, Edoardo Conte, Dario Pellegrini, Alfonso Ielasi, Daniele Andreini, Martin Penicka, Jacopo Andrea Oreglia, Paolo Calabrò, Antonio Bartorelli, Carmine Pizzi, Tullio Palmerini, Marc Vanderheyden, Francesco Saia, Flavio Ribichini, Emanuele Barbato
Publikováno v:
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-12 (2024)
Abstract Background A substantial number of patients with severe aortic stenosis (AS) undergoing transcatheter aortic valve implantation (TAVI) experience adverse events after TAVI, with health care expenditure. We aimed to investigate cardiac remode
Externí odkaz:
https://doaj.org/article/1fc8effcb9c243e19a4efdcc3a908deb
Autor:
Antonella Tommasino, Federico Dell’Aquila, Marco Redivo, Luca Pittorino, Giulia Mattaroccia, Federica Tempestini, Stefano Santucci, Matteo Casenghi, Francesca Giovannelli, Stefano Rigattieri, Andrea Berni, Emanuele Barbato
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 11, Iss 11, p 338 (2024)
Background: a wider left main bifurcation angle (LMBA) has been linked to severe plaque development in the proximal left anterior descending artery (LAD). This study aimed to identify predictors of severe proximal LAD stenosis and major adverse cardi
Externí odkaz:
https://doaj.org/article/6a58db9b1b0241f6935d0d1b5cc6c39f
Autor:
Luca Testa, Antonio Popolo Rubbio, Mattia Squillace, Flavio Albano, Vincenzo Cesario, Matteo Casenghi, Giuseppe Tarantini, Paolo Pagnotta, Alfonso Ielasi, Grigore Popusoi, Leonardo Paloscia, Alessandro Durante, Diego Maffeo, Francesco Meucci, Giuliano Valentini, Gian Paolo Ussia, Paolo Cioffi, Bernardo Cortese, Giuseppe Sangiorgi, Gaetano Contegiacomo, Francesco Bedogni
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2023)
BackgroundThe Cocoon patent foramen ovale (PFO) Occluder is a new generation nitinol alloy double-disk device coated with nanoplatinum, likely useful in patients with nickel hypersensitivity. Early results and mid-term outcomes of this device in perc
Externí odkaz:
https://doaj.org/article/2e5859e0636142088eb051fd08c7602d
Autor:
Luca Testa, Matteo Casenghi, Enrico Criscione, Nicolas M. Van Mieghem, Didier Tchétché, Anita W. Asgar, Ole De Backer, Azeem Latib, Bernhard Reimers, Giulio Stefanini, Carlo Trani, Francesco Giannini, Antonio Bartorelli, Wojtek Wojakowski, Maciej Dabrowski, Dariusz Jagielak, Adrian P. Banning, Rajesh Kharbanda, Raul Moreno, Joachim Schofer, Christina Brinkmann, Niels van Royen, Duane Pinto, Antoni Serra, Amit Segev, Arturo Giordano, Nedy Brambilla, Mauro Agnifili, Antonio Popolo Rubbio, Mattia Squillace, Jacopo Oreglia, Rudolph Tanja, James M. McCabe, Alexander Abizaid, Michiel Voskuil, Rui Teles, Giuseppe Biondi Zoccai, Lars Sondergaard, Francesco Bedogni
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundA severe prosthesis-patient mismatch (PPM) is associated with adverse outcomes following transcatheter aortic valve replacement (TAVR) for de novo aortic stenosis or a failed surgical bioprosthesis. The impact of severe PPM in patients unde
Externí odkaz:
https://doaj.org/article/6879a92298364ddeb29b433b17d6c76a
Autor:
Matteo Casenghi, MD, Omar A. Oliva, MD, Mattia Squillace, MD, Michele Bellamoli, MD, Enrico Poletti, MD, Antonio Popolo Rubbio, MD, Luca Testa, MD, PhD, Francesco Bedogni, MD, Federico De Marco, MD, PhD
Publikováno v:
JACC: Case Reports, Vol 3, Iss 4, Pp 678-681 (2021)
Redo transcatheter aortic valve replacement (TAVR) may pose the risk of coronary flow obstruction. We report 2 cases of severe TAVR regurgitation due to different physiopathological mechanisms in which TAVR-in-TAVR could be at high risk for sinus seq
Externí odkaz:
https://doaj.org/article/55728f75310c4b34b6dfc48181610dbd
Autor:
Antonio Sisinni, Matteo Casenghi, Antonio Popolo Rubbio, Andrea Berni, Francesco Bedogni, Emanuele Barbato
Publikováno v:
Reviews in Cardiovascular Medicine, Vol 24, Iss 5, p 128 (2023)
Pharmacological treatment is the cornerstone therapy of heart failure with reduced ejection fraction (HFrEF). In addition, several percutaneous techniques have been developed to treat symptomatic patients, with specific heart failure (HF) phenotypes
Externí odkaz:
https://doaj.org/article/d525ab06c51d45ada27f1b70365851e6
Publikováno v:
Annals of Pediatric Cardiology, Vol 14, Iss 2, Pp 228-230 (2021)
Atrial septal defect (ASD) associated with left ventricular (LV) diastolic dysfunction (DD) is rare in children. DD is common in elderly patients undergoing ASD closure. Restrictive physiology among children undergoing percutaneous ASD closure is som
Externí odkaz:
https://doaj.org/article/0958b0a85f314a0da751d9964d26d453
Autor:
Sara Baggio, Matteo Pagnesi, Won-Keun Kim, Andrea Scotti, Marco Barbanti, Giuliano Costa, Marianna Adamo, Ran Kornowski, Hana Vaknin Assa, Rodrigo Estévez-Loureiro, Robert Alarcón Cedeño, Federico De Marco, Matteo Casenghi, Stefan Toggweiler, Verena Veulemans, Darren Mylotte, Mattia Lunardi, Damiano Regazzoli, Bernhard Reimers, Lars Sondergaard, Maarten Vanhaverbeke, Philippe Nuyens, Diego Maffeo, Andrea Buono, Matteo Saccocci, Francesco Giannini, Luca Di Ienno, Marco Ferlini, Giuseppe Lanzillo, Alfonso Ielasi, Joachim Schofer, Christina Brinkmann, Jan Van Der Heyden, Ian Buysschaert, Amnon Eitan, Alexander Wolf, Martin Marian Adamaszek, Antonio Colombo, Azeem Latib, Antonio Mangieri
Publikováno v:
EuroIntervention. 18:977-986
The ACURATE neo2 (NEO2) and Evolut PRO/PRO+ (PRO) bioprostheses are new-generation self-expanding valves developed for transcatheter aortic valve replacement (TAVR).We sought to compare the performance of the ACURATE neo2 and Evolut PRO/PRO+ devices.
Autor:
Andrea Scotti, Matteo Pagnesi, Won-Keun Kim, Ulrich Schäfer, Marco Barbanti, Giuliano Costa, Sara Baggio, Matteo Casenghi, Federico De Marco, Maarten Vanhaverbeke, Lars Sondergaard, Alexander Wolf, Joachim Schofer, Marco Bruno Ancona, Matteo Montorfano, Ran Kornowski, Hana Vaknin Assa, Stefan Toggweiler, Alfonso Ielasi, David Hildick-Smith, Stephan Windecker, Albrecht Schmidt, Andrea Buono, Diego Maffeo, Dimytri Siqueira, Francesco Giannini, Marianna Adamo, Mauro Massussi, David A. Wood, Jan-Malte Sinning, Jan Van Der Heyden, Dirk-Jan van Ginkel, Nicholas Van Mieghem, Verena Veulemans, Darren Mylotte, Vasileios Tzalamouras, Maurizio Taramasso, Rodrigo Estévez-Loureiro, Antonio Colombo, Antonio Mangieri, Azeem Latib
Publikováno v:
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 18(10), 804-811. EuroPCR
BACKGROUND Transcatheter aortic valve replacement (TAVR) with the ACURATE neo device has been associated with a non-negligible incidence of paravalvular aortic regurgitation (AR). The new-generation ACURATE neo2 has been designed to mitigate this lim
Publikováno v:
Cardiovascular Revascularization Medicine. 42:161-170
Over the last two decades there has been a significant shift towards the use of bioprostheses in the context of surgical aortic valve replacement, despite the well-known process of structural valve deterioration (SVD). This process has been extensive